RYZB

RayzeBio, Inc. Common Stock
RYZB

Overview Fund Activity
Delisted

RYZB was delisted on the 23rd of February, 2024.

Back to rankings

107 hedge funds and large institutions have $3.41B invested in RayzeBio, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 59 funds opening new positions, 19 increasing their positions, 18 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
107
Holders Change
+39
Holders Change %
+57.35%
% of All Funds
1.57%
Holding in Top 10
18
Holding in Top 10 Change
+10
Holding in Top 10 Change %
+125%
% of All Funds
0.26%
New
59
Increased
19
Reduced
18
Closed
20
Calls
–
Puts
$2.7M
Net Calls
-$2.7M
Net Calls Change
-$2.7M

Top Buyers

1
BlackRock
1
BlackRock
New York
$85.1M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$72.7M
3
AAM
3
Alpine Associates Management
Florida
$47.4M
4
LGM
4
Logos Global Management
California
$35.3M
5
Balyasny Asset Management
5
Balyasny Asset Management
Illinois
$33.6M

Top Sellers

1
Capital Research Global Investors
1
Capital Research Global Investors
California
$10.6M
2
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$690K
3
Fidelity Investments
3
Fidelity Investments
Massachusetts
$15.2M
4
VC
4
Vivo Capital
California
$6.87M
5
SCV
5
Sands Capital Ventures
Virginia
$48.4M
Name Holding Trade Value Shares
Change 		Shares
Change %
Walleye Capital
126
Walleye Capital
New York
– -$330K -14,847 Closed
Norges Bank
127
Norges Bank
Norway
– -$222K -10,000 Closed
2 3 4 5
6